Composition:
Dexnova 30 Capsule: Each dual delayed release capsule contains Dexlansoprazole INN 30 mg as enteric coated pellets.
Dexnova 60 Capsule: Each dual delayed release capsule contains Dexlansoprazole INN 60 mg as enteric coated pellets.

Indication:
• Healing of Erosive Esophagitis: Dexnova (Dexlansoprazole) is indicated for healing of all grades of Erosive Esophagitis (EE) for up to 8 weeks.
• Maintenance of Healed Erosive Esophagitis: Dexnova (Dexlansoprazole) is indicated to maintain healing of EE and relief of heartburn for up to 6 months.
• Symptomatic Non-Erosive Gastroesophageal Reflux Disease: Dexnova (Dexlansoprazole) is indicated for the treatment of heartburn associated with symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD) for upto 4 weeks.